Filter
1972
Text search:
novel
Featured
251
206
Language
Document type
578
491
421
127
105
92
47
28
28
18
18
14
4
1
Countries
128
84
57
55
51
47
47
44
40
31
30
29
27
26
25
22
21
21
20
18
17
16
15
15
15
14
13
13
13
13
13
12
12
11
10
10
10
9
9
8
8
8
7
7
7
7
7
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
665
113
105
56
44
33
15
Toolboxes
862
124
102
87
86
76
49
47
45
42
36
36
36
31
29
23
19
16
15
11
10
7
6
5
5
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Framework for implementation.
The END TB Strategy.
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
The End TB Strategie
Update 2021; Immunization, Vaccines and Biologicals
Accessed December 2017
ERJ Open Res 2017; 3: 00002-2017
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M
...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o
...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also i
...
